KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Short-term Investments (2018 - 2025)

Historic Short-term Investments for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $5.2 billion.

  • BioNTech SE's Short-term Investments fell 3336.71% to $5.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 billion, marking a year-over-year decrease of 3336.71%. This contributed to the annual value of $7.5 billion for FY2024, which is 4275.01% up from last year.
  • According to the latest figures from Q3 2025, BioNTech SE's Short-term Investments is $5.2 billion, which was down 3336.71% from $4.3 billion recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Short-term Investments peaked at $7.8 billion during Q3 2024, and registered a low of $603118.0 during Q1 2021.
  • Its 5-year average for Short-term Investments is $3.2 billion, with a median of $2.5 billion in 2023.
  • As far as peak fluctuations go, BioNTech SE's Short-term Investments plummeted by 5573.48% in 2022, and later soared by 2772745.6% in 2023.
  • Over the past 5 years, BioNTech SE's Short-term Investments (Quarter) stood at $436.5 million in 2021, then crashed by 55.73% to $193.2 million in 2022, then skyrocketed by 2620.16% to $5.3 billion in 2023, then surged by 42.75% to $7.5 billion in 2024, then tumbled by 30.91% to $5.2 billion in 2025.
  • Its Short-term Investments stands at $5.2 billion for Q3 2025, versus $4.3 billion for Q2 2025 and $4.1 billion for Q1 2025.